We present a case of central nervous system (CNS) infection due to Stomatococcus mucilaginosus involving a patient with leukemia and summarize 12 additional published reports of CNS infection due to this organism in immunocompromised hosts. The infection was diagnosed most commonly in the setting of hematologic malignancy accompanied by chemotherapy-induced neutropenia. S. mucilaginosus was recovered from blood prior to discovery of the CNS infection in 62% of cases. Signs or symptoms of CNS infection were observed in all patients. Although a number of patients responded to regimens containing intravenous vancomycin, the addition of intrathecal vancomycin appeared to be of benefit in some cases.
We present a case of central nervous system (CNS) infection due to Stomatococcus mucilaginosus involving a patient with leukemia and summarize 12 additional published reports of CNS infection due to this organism in immunocompromised hosts. The infection was diagnosed most commonly in the setting of hematologic malignancy accompanied by chemotherapy-induced neutropenia. S. mucilaginosus was recovered from blood prior to discovery of the CNS infection in 62% of cases. Signs or symptoms of CNS infection were observed in all patients. Although a number of patients responded to regimens containing intravenous vancomycin, the addition of intrathecal vancomycin appeared to be of benefit in some cases.
Stomatococcus mucilaginosus (formerly referred to as Microbegun with oral ciprofloxacin. On the fourth hospital day, chemotherapy was initiated with cyclophosphamide (300 mg/m 2 coccus mucilaginosus or Staphylococcus salivarius) is a slimeproducing, catalase-variable, encapsulated gram-positive coccus iv q12h 1 6 doses), doxorubicin (50 mg/m 2 iv 1 1 dose), vincristine (2 mg iv 1 1 dose), and dexamethasone (40 mg po found as part of the normal flora of the human mouth. Infections due to this organism in immunocompetent individuals have occaqd 1 4 days), followed by repeated doses of vincristine and dexamethasone 1 week later. sionally been reported [1, 2] . In recent years, S. mucilaginosus has been recognized as an emerging pathogen in patients rendered A routine lumbar puncture (LP) performed on day 8, before neutropenic from cancer treatments [3, 4] . In this population, the administration of intrathecal methotrexate and cytosine arabacteremic infections complicated by septic shock, pneumonia, binoside, yielded sterile CSF with 0 WBCs/mm 3 . Fever (temdermatologic manifestations, adult respiratory distress syndrome, perature to 38ЊC) occurred on day 17, along with complaints and meningitis have been observed [3, 4] .
of throat pain, ear pain, and headache. Empirical therapy with We recently treated an adult leukemic patient who had a iv ceftazidime and vancomycin was started. Over the next 48 complicated CNS infection due to S. mucilaginosus. The unhours, the patient's headache persisted and difficulty in naming usual clinical course we observed and our difficulty in identiobjects was observed. A contrast CT scan of the brain revealed fying S. mucilaginosus as the infecting organism prompted nonspecific ischemic changes. Cultures of blood obtained at us to review the literature regarding S. mucilaginosus CNS the onset of fever yielded gram-positive cocci. infections in immunocompromised patients. Our goal was to Although the fever diminished after initiation of iv antibiotfurther characterize the clinical characteristics of S. mucilagiics, increasing somnolence was observed, and an LP was nosus CNS infection and responses to therapies used for this performed on day 20. Analysis of the CSF showed many intrainfection. cellular gram-positive cocci, 490 WBCs/mm 3 (76% polymorphonuclear leukocytes), a glucose level of 25 mg/dL, and a CSF protein level of 258 mg/dL. Oral rifampin (600 mg daily) Case Report was added to the regimen and the iv vancomycin dose was increased from 1,000 mg to 1,500 mg (q12h). Because blood The patient was a 60-year-old woman hospitalized for newly cultures remained positive, the central venous catheter was diagnosed acute lymphocytic leukemia. At the time of admisremoved. sion the neutrophil count was 422/mm 3 , was present in 85% of paadded to both the left and right lateral ventricles. Although the tients at the time that the first positive culture for S. mucilaginopatient's mental status began to improve following decompressus was documented. Adults accounted for 31% of cases, while sion of the ventricles, the CSF remained mucoid in appearance 69% of cases involved children £18 years of age. and continued to yield intracellular organisms. These findings Clinical presentations. Fever occurred at or near the onset led to an increase in the dose of vancomycin administered of symptoms of the CNS infection in 11 of 13 cases. In all 13 through each ventriculostomy tube, to 10 mg daily.
cases, signs or symptoms indicating the CNS as a possible On day 29 the laboratory identified the isolates obtained site of infection were noted. Alterations in mental status, as from blood and the original spinal fluid isolates as S. mucilagievidenced by lethargy, confusion, seizures, or unresponnosus. This identification was based on findings of gram-posisiveness, occurred in 7 (54%) of 13, and neck pain or neck tive cocci in clusters with a negative catalase test, susceptibility stiffness was present in 4 (31%) of 13. Of the three patients to vancomycin, a positive leucine aminopeptidase test, esculin without documented mental status changes or neck pain or hydrolysis, lack of growth in 6.5% NaCl, and a positive pyrazineck stiffness, two had fever, headache, and emesis, while namidase test. After we reviewed the literature regarding the the remaining patient was reported as having a ''syndrome antimicrobial susceptibilities of this bacterium, clarithromycin consistent with meningitis.'' was added to the regimen and subcutaneous granulocyte colony Blood and CSF findings at time of diagnosis. Blood culstimulating factor (GCSF) was given to increase the peripheral tures yielding S. mucilaginosus were documented prior to the WBC count to 20,000/mm 3 . discovery of the CNS infection in eight (62%) of 13 cases. With regard to these eight patients, signs and/or symptoms The CSF was found to be cleared of the organism on day prompting an evaluation for CNS infection were present at the 34, and treatment with iv vancomycin and cefotaxime, intratime blood cultures were performed in 2 cases, within 72 hours ventricular vancomycin, GCSF, and oral rifampin and clarithroof the positive blood culture in 3, 12 days following documentamycin was given for a 21-day course following ventricular tion of S. mucilaginosus bacteremia in 1, 17 days following decompression. During the hospital stay the hydrocephalus redocumentation of S. mucilaginosus bacteremia in 1, and Ç6 solved completely and the leukemia was noted to be in remisweeks after a positive blood culture in the remaining case. sion. The patient was discharged to home on hospital day 48.
The CSF gram stain showed gram-positive cocci in 11 of During 14 months of follow-up, there was complete recovery 12 cases for which data were available, although in one the of neurological function and no evidence of recurrent S. mucibacteria were visualized only after a second LP was performed. laginosus infection.
Cultures of CSF yielded the organism in all 13 cases (100%), although one patient had a positive culture noted only after a second LP. Among the 8 cases for which CSF cell counts were Methods reported, the CSF WBC count was elevated at the initial LP in 4 cases and at a second LP in 2 but was normal in the We performed a MEDLINE-based search of the literature remaining 2. from 1966 to the present, using the key words Stomatococcus, Brain imaging studies. Results of CT or MRI brain scans Micrococcus, and Staphylococcus salivarius. We also reviewed were available for nine cases and were abnormal in four. For relevant bibliographies in order to identify previously published three of the four cases with abnormal scans, pathological encases of CNS S. mucilaginosus infections. Our case definition hancement of the choroid plexus and ependyma were docuincluded immunocompromised patients with underlying hemamented after contrast CT and/or MRI scans with gadolinium, tologic malignancy, solid tumor, and lymphoma and patients while in the remaining case slight enlargement of the CSF who had received immunosuppressive medications and were spaces was attributed to administration of chemotherapy. Hyreported to have had an illness associated with the presence of drocephalus was documented in one case. Abnormal enhancement of the meninges was not identified in any imaging study.
S. mucilaginosus in CSF.
/ 9c5b$$no44 10-14-98 15:52:47 cida UC: CID Antimicrobial susceptibilities of clinical isolates. Data repatients [14] . Previously published reviews of CNS infections in immunocompromised patients have not included infections garding the antimicrobial susceptibilities of the S. mucilaginosus isolates recovered from clinical specimens were available due to this pathogen [15, 16] . Our case plus those identified in the literature review totaled for 10 of 13 cases. Isolates were noted to be resistant to penicillin in 7 (70%) of 10 cases tested; all 10 (100%) of these isolates 13 cases of S. mucilaginosus CNS infection occurring in immunocompromised patients. The majority of patients in our review were susceptible to vancomycin. The five isolates tested against rifampin were susceptible to this agent.
were neutropenic from chemotherapy. As one case involved a premature infant receiving high doses of corticosteroids, it is Treatment. As shown in table 1, multiple antimicrobial agents were used to treat the S. mucilaginosus CNS infections possible that impaired neutrophilic function due to steroid use was a predisposing factor for infection in that patient. Our in this series. Because many of the patients were receiving empirical broad-spectrum antimicrobials for neutropenic fever, literature search revealed only one report of CNS infection with this organism in a nonimmunocompromised patient: a it is likely that many of the antimicrobials used were not initially directed at the S. mucilaginosus infection. All 13 patients patient with a CNS infection complicating surgical drainage of a subdural hematoma [2] . were treated with vancomycin at some time after the onset of infection, and 12 (92%) of 13 received iv vancomycin (1 of We noted that signs and symptoms of CNS infection developed in some patients during or after treatment with antibiotics the 13 received vancomycin only by the intrathecal route). For seven (54%) of the 13 patients, adjunctive treatment with active against S. mucilaginosus. In a series of neutropenic patients with CNS infections due predominantly to gram-negative intrathecal vancomycin and or oral rifampin was used. Intrathecal vancomycin was used in 5 (38%) of 13 cases, while rifambacteria, 67% were receiving antibiotics appropriate for the offending organism when the CNS infection was discovered, pin was used as an adjunctive antimicrobial in 3 (23%) of 13.
These treatments were typically added to the antimicrobial suggesting that this finding is not distinctive for S. mucilaginosus [15] . In that series, negligible meningeal inflammation was regimen either because the patient who had developed the CNS infection had previously received vancomycin or because the observed in the majority of patients who were autopsied, leading the investigators to hypothesize that neutropenia was assoorganisms persisted in the CSF despite therapy with iv antibiotic(s) to which the S. mucilaginosus isolate was susceptible in ciated with reduced meningeal inflammation, resulting in suboptimal concentrations of antimicrobials in the CNS [15] . vitro. For four of five patients treated with adjunctive intrathecal vancomycin, the drug was apparently given by the lumbar It is interesting that meningeal enhancement was not reported for any of the brain scans reported in our review, a route. For the remaining patient treated with adjunctive intrathecal vancomycin, the medication was initially given by finding supporting the hypothesis that meningeal inflammation may be reduced in neutropenic patients despite the presthe lumbar route and later given through the intraventricular route. Chloramphenicol or thiamphenicol was added to the ence of bacteria in the CSF. As S. mucilaginosus is encapsulated and growth of this organism is characterized by slime therapy for three patients.
Outcomes. In this series, 4 (31%) of 13 patients with production, it is possible that these microbiological factors may contribute to the difficulty in clearing this organism from S. mucilaginosus CNS infection died during the hospitalization associated with the infection; death was clearly attributed to an infected site. At our institution, we had difficulty in identifying S. mucilagthe CNS infection in 3 of these 4 cases. Seizure activity in all four patients who died was reported, while no seizure activity inosus as the offending pathogen. On blood agar, this organism typically forms nonhemolytic white to gray transparent colowas reported for the nine survivors. One of 5 patients (20%) who received adjunctive intrathecal vancomycin died, while 3 nies that are mucoid, and older colonies adhere to the agar surface. These features may give rise to a presumptive identifiof 8 patients (38%) who did not receive intrathecal vancomycin died. For patients who survived the infection, recovery without cation of either a coagulase-negative Staphylococcus or Streptococcus species [17] . Additional difficulties may arise, as permanent sequelae was common, and improvement or resolution of the brain scan abnormalities was noted for the three S. mucilaginosus may be misidentified by conventional or commercial systems (Vitek or API STAPH-Trac, Plainview, NY) patients with abnormalities evident on brain scans at the time of diagnosis of the CNS infection.
[17]. S. mucilaginosus can be identified with use of standard procedures for differentiation of gram-positive coccal organisms with negative or weak catalase reactions (as performed Discussion in our case) or through the use of antimicrobial disk testing [17, 18] . In recent years an increasing incidence of gram-positive infections has been observed in patients with cancer treated with A study of the antimicrobial susceptibilities of 63 isolates of S. mucilaginosus demonstrated that all isolates were suscepcytotoxic agents. Along with this observation, S. mucilaginosus has been added to the bacterial causes of fever listed in an tible to vancomycin. In that study, rifampin was the most active agent, while imipenem, cefotaxime, and clarithromycin also updated guideline of the Infectious Diseases Society of America concerning the use of antimicrobials in neutropenic had activity [19] . Although no high-level resistance to penicil-/ 9c5b$$no44 10-14-98 15:52:47 cida UC: CID 
